Finland invests into novel EU life sciences infrastructure
Helsinki –Finland is investing EUR1.9m in creating world class bioinformatics, biobanking and translational research infrastructures. The investment comes as part of the linkage of three large EU projects ELIXIR, BBMRI, and EATRIS, with the objective of rapid translation from research into biomarkers and diagnostics. The investment fits the strategy of Science Manager Eeri Vuori, who heads BBMRI , a project that coordinates biomarker discovery on 100 million existing samples stored in Europe’s widespread biobanks (more), and has close links to EATRIS chief Rudi Balling. Funding of EUR1m is provided by the Ministry of Education through the Academy of Finland, with EUR0.85m co-financing from a consortium consisting of the Institute for Molecular Medicine Finland (FIMM), CSC – IT Center for Science Ltd and the National Institute for Health and Welfare (THL).